HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AbstractPURPOSE:
to assess specificities of course of the long-QT syndrome in children before and after implantation of cardioverter-defibrillator (ICD), and optimization of indications to ICD-therapy.
MATERIALS AND METHODS:
We included in this study 48 children with long-QT syndrome from 44 unrelated families (28 boys and 20 girls), who underwent ICD implantation at the mean age 11.8±3.8 years. Mean duration of follow-up after implantation was 5.2±2.8 years. Data from these children were compared with those from 59 children of comparable age and gender with long-QT syndrome from 46 unrelated families receiving antiarrhythmic therapy (β-adrenoblockers). We assessed clinical and electrocardiographic characteristics of the disease obtained at initial visit and their dynamics thereafter.
RESULTS:
Children with long-QT syndrome and ICD were mainly probands with interval QT longer than 500 ms, recurrent syncope and often history of sudden cardiac arrest requiring high doses of β-adrenoblockers for control of ventricular tachyarrhythmias.
CONCLUSION:
ICD implantation is an effective and safe method both of primary and secondary prevention of sudden cardiac death in children with long-QT syndrome.
AuthorsR A Ildarova, M A Shkolnikova, S A Termosesov
JournalKardiologiia (Kardiologiia) Vol. 58 Issue 12 Pg. 52-58 (Dec 25 2018) ISSN: 0022-9040 [Print] Russia (Federation)
Vernacular TitleImplantation of Cardioverter-Defibrillator in Children With Long-QT Syndrome: Assessment of Indications, Efficacy, and Safety Based on 10-Year Experience.
PMID30625097 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Arrhythmias, Cardiac
  • Child
  • Death, Sudden, Cardiac
  • Defibrillators, Implantable
  • Electrocardiography
  • Female
  • Humans
  • Long QT Syndrome
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: